Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-049090)

Filing Details

Accession Number:: 0001209191-19-049090
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-10 19:11:59
Reporting Period:: 2019-09-06

Accepted Time:: 2019-09-10 19:11:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1759425	Mirum Pharmaceuticals Inc.	MIRM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614740	Christopher Peetz	C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-06	4,750	$10.91	192,250	No	4	P	Indirect	By The Peetz Family Trust
Common Stock	Acquisiton	2019-09-09	2,000	$10.90	194,250	No	4	P	Indirect	By The Peetz Family Trust
Common Stock	Acquisiton	2019-09-09	2,320	$11.35	196,570	No	4	P	Indirect	By The Peetz Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By The Peetz Family Trust
No	4	P	Indirect	By The Peetz Family Trust
No	4	P	Indirect	By The Peetz Family Trust

Footnotes

The weighted average purchase price for the transaction reported was $10.90645, and the range of prices were between $10.45 and $11.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.